ACE2 expression was also examined in the heart, another major target organ of SARS-CoV-2, where ACE2 immunoreactivity was detected in association with myocardial microvasculature in both control (Fig 3H) and COVID-19 specimens (S1 Fig). This evidence concerns the gene ACE2 and COVID-19.